VCBeat Health
Contact Us
Home
China Healthcare Select
Insights
MNC China Lens
Vertical Industries
Services
Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory
About VCBeat
Why VCBeat
Log In
Home
J&J Upgraded — New Drug Approved in China, Q1 Revenue Beats
J&J Upgraded — New Drug Approved in China, Q1 Revenue Beats
May 23, 2026 00:47 CST Updated 01:28
Share:
Johnson & Johnson
Medical Device R&D and Manufacturer